InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,770.31
(
1.01%
)
US TECH 100
19,676.00
(
1.21%
)
Dow Jones
42,151.37
(
0.85%
)
Brent Oil
75.29
(
0.23%
)
Bitcoin
69,968.55
(
3.17%
)

Vita 34 International Ag fka VTIAF

1
Follow
1

Vita 34 International Ag fka VTIAF

1
Follow
1
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up
Live Updating
profile icon
MinnieM Free
02/24/10 12:16 PM
Post #4
Re: #3: @locksflooring - 2 different symbols for the Same company doesnt
Last Read
profile icon
locksflooring Free
02/24/10 12:02 PM
Post #3
Re: #2: @MinnieM - I used to be mod on it.
Last Read
profile icon
MinnieM Free
02/24/10 11:31 AM
Post #2
Re: #1: @locksflooring - I thought we had this one!
Last Read
profile icon
locksflooring Free
02/24/10 9:42 AM
Post #1
Last Read

Vita 34 International Ag fka VTIAF RSS Feed

Followers
1
Posters
3
Posts (Today)
0
Posts (Total)
7
Created
02/24/10
Type
Free
Moderators

Vita 34 International AG (VTIAF, frankfurt V3V)

 

 

Vita 34 was founded in 1997 by doctors in Leipzig as the first bank for blood of the umbilical cord for private use in Europe.

 

http://www.vita34.de/vita/en/

 

Reporting is done in the EU and it is Grey in the US market due to lack of info, And, remember to adjust for exchange rate if you decide to trade it.

 

 

Company Information:

Vita 34 AG
Deutscher Platz 5
04103 Leipzig
Germany

Free advice:
Mo-Fr 8:00 to 20:00
08000/34 00 00 (D)
008000/34 00 000 (A/CH)

Consultation in Switzerland:
Tue 13:30 to 14:30
0800/ 800 034 (toll-free)
Mrs.Sandra Müller Buro
vita34@contextesante.ch

+ Agree Call back

 

Vita 34 – the company

In Germany-speaking countries, Vita 34 is the oldest and most experienced bank for blood of the umbilical cord for private use. In its founder, Dr Eberhard Lampeter, the company is headed by a pioneer in storing blood of the umbilical cord. Its excellent position is for Vita 34 a challenge and commitment: We are therefore working so that the storage of the blood of the umbilical cord, which is rich in stem cells, becomes generally known and even standard in the medium term.

 

 

Management: 

 

Important Company Highlights: 

 

Vita 34 AG is Germany’s oldest and biggest bank for blood of the umbilical cord for private use. The company, which was founded in 1997 as a limited company, has been a joint-stock company since 2002.  

About Vita 34 

  • Established in April 1997 
  • Head office and an own stem cell laboratory in Leipzig 
  • 107 employees (status 06/2009) 
  • more than 63,000 stored blood of the umbilical cord preparations (status 09/2009) 
  • 11 applications of stored blood of the umbilical cord in children
  • Business activities: recovery, preparation, long-term storage of blood and stem cell products for the treatment of various disease patterns 
  • Vita 34 is a 100% subsidiary of Vita 34 International AG. The shareholders of this holding are the founders, the management as well as institutional investors from Germany and the US

 Research initiatives 

  • University of Leipzig and IKP Gatersleben:
    Dr Michael Cross and Prof Anna Wobus
    "Differentiation of stem cells from the blood of the umbilical cord" 
  • Fraunhofer Institute for Cell Therapie and Immunology 
    Prof Frank Emmerich and Dr Johannes Boltze
    "Stroke treatment" and "The therapeutic effectiveness of adult stem cells depending on the age of the cell population and the recipient organism"
  • Translational Centre for Regenerative Medicine, Leipzig:
    Dr Rüdiger Alt
    „Establishment and evaluation of VSEL stem cells for tissue repair“
  • University of Leipzig:
    Dr Manja Kamprad
    "Proliferation of stem cells from the blood of the umbilical cord" 
  • University of Rostock:
    Prof Gustav Steinhoff
    "Heart attack treatment"
  • Technical University of Munich:
    Prof Annette-Gabriele Ziegler
    "Treatment of diabetes type 1"

Board of Directors

  • Dr Eberhard Lampeter, CEO 
  • Jörg Ulbrich, CFO

Supervisory Board

  • Richard J. Neeson (Chairman) 
  • Dr Uwe Marx 
  • Dr Holger Födisch

Scientific Advisory Board

  • Prof Wolfgang Holzgreve
    (Head Physician and President of the Director's Board of the Clinic, University of Freiburg) 
  • Prof Eckart Wunder
    (Head of the Laboratory for Stem Cell Research at the Institute for Haematological Research of the CHM-Hôpital du Hasenrain in Mulhouse, France) 
  • Prof Gustav Steinhoff
    (Director of the Clinic and Policlinic for Heart Surgery, Medical Faculty of Rostock)

 

Recent News: 

http://ir.vita34.de/cgi-bin/show.ssp?companyName=vita34&language=English&id=2000

 

 

Annual Reports:

http://ir.vita34.de/cgi-bin/show.ssp?companyName=vita34&language=English&id=4000

 

 

Transfer Agent:

 

 

Shareholder Structure

20.7%             Independence Blue Cross (IBC)

15.8%             Landesbank Baden- Württemberg

15.0%             Founder/Management*

48.5%             Free float (<5%)

                        *This only includes founders/management with a stake of 5% or above.

 

 

 

 

 

Please request chart here.  Ask for ticker VTIAF

http://stockcharts.com/help/doku.php?id=support:feedback:symbol_request

 

 

Reporting is done in the EU and it is Grey in the US market due to lack of info, And, remember to adjust for exchange rate if you decide to trade it.

 

 

Rules of the board according to IHUB:
http://www.investorshub.com/boards/complex_terms.asp

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Board Info
Posts Today
0
Posts (Total)
7
Posters
3
Moderators
New Post